期刊文献+

CK19、Ki67、galectin3在甲状腺乳头状癌中的表达及临床意义

Expression and clinical significance of CK19,Ki67 and galectin-3 in papillary thyroid carcinoma
下载PDF
导出
摘要 目的:探究细胞角蛋白19(Cytokeratin 19,CK19)、Ki67、半乳糖凝素-3(galectin3)在甲状腺乳头状癌(Papillary thyroid carcinoma,PTC)中的表达及与病理特征的关系。方法:搜集2021年1月到2023年12月医院收治的68例PTC患者临床资料,免疫组化检查癌组织及癌旁组织中CK19、Ki67、galectin3阳性表达率,分析三者与患者病理特征的关系。结果:PTC癌组织中CK19、Ki67、galectin3阳性表达率明显高于癌旁组织(P<0.05)。不同肿瘤直径、病灶数量、分化类型、临床分期PTC患者癌组织中CK19、Ki67阳性表达率差异有统计学意义(P<0.05)。结论:PTC患者癌组织CK19、Ki67、galectin3阳性表达率高,CK19和Ki67阳性表达与肿瘤大小、数量和分化程度及病理分期有一定关联。 Objective:To explore the expression of cytokeratin 19(CK19),Ki67 and galectin-3 in papillary thyroid carcinoma(PTC)and their relationship with pathological features.Methods:The clinical data of 68 PTC patients admitted to the hospital from January 2021 to December 2023 were collected.The positive expression rates of CK19,Ki67 and galectin-3 in cancer tissues and adjacent tissues were detected by immunohistochemistry.The relationship between the three indexes and the patients’pathological features was analyzed.Results:The positive expression rates of CK19,Ki67 and galectin-3 in PTC tissues were significantly higher than those in adjacent tissues(P<0.05).There were statistically significant differences in the positive expression rates of CK19 and Ki67 in cancer tissues of PTC patients with different tumor diameters,number of lesions,differentiation types,and clinical stages(P<0.05).Conclusion:The positive expression rates of CK19,Ki67 and galectin-3 in cancer tissues of PTC patients are high,and the positive expressions of CK19 and Ki67 are correlated with tumor size,quantity,differentiation degree,and pathological staging.
作者 苏小娟 李斌 陈婷 Su Xiao-juan;Li Bin;Chen Ting(Pathology Department,The People's Hospital of Ningdu,Ganzhou 342800,Jiangxi,China;General Surgery Department,The People's Hospital of Ningdu,Ganzhou 342800,Jiangxi,China)
出处 《四川生理科学杂志》 2024年第9期1964-1967,共4页
关键词 甲状腺乳头状癌 CK19 KI67 galectin3 病理特征 Papillary thyroid carcinoma Cytokeratin 19 Ki67 Galectin-3 Pathological feature
  • 相关文献

参考文献9

二级参考文献81

  • 1郑璐滢,朱建善,王家东,许雁萍.Galectin-3、CK19和TPO表达在甲状腺良恶性肿瘤病理诊断中的价值[J].临床与实验病理学杂志,2005,21(4):449-453. 被引量:18
  • 2王晓红,刘雨飞,鲍宇浓,崔全才,王德田.甲状腺乳头状癌RET、CK19、TG、Ki-67的表达[J].临床与实验病理学杂志,2006,22(6):692-695. 被引量:14
  • 3Sahoo S, Hoda S A, Rosai J, et al. Cytokeratin 19 immunoreac- tivity in the diagnosis of papillary thyroid carcinoma: a note of cau- tion[J]. Am J Clin Pathol, 2001,116(5) :696 -702.
  • 4de Matos P S, Ferreira A P, de Oliverira Facuri F,et al. Useful- ness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy[ J]. Histopathology, 2005, 47 (4) :391 -401.
  • 5Beesley M F, Mclaren K M. Cytokeratin 19 and galectin-3 immu- nohistochemistry in the differential diagnosis of solitary thyroid nodules[ J]. Histopathology, 2002, 41 (3) : 236 - 43.
  • 6Kawachi K, Matsushita Y, Yonezawa S,et al. Galectin-3 expres- sion in various thyroid neoplasms and its possible role in metastasis formation [ J ]. Hum Pathol,2000,31 ( 4 ) :428 - 33.
  • 7Rossi E D, Raffaelli M, Mule A,et al. Simultaneous immunohis- tochemical expression of HBME-1 and galectin-3 differentiates pa- pillary carcinomas from hyperfunctioning lesions of the thyroid [ J ]. Histopathology, 2006, 48 (7) :795 - 800.
  • 8Cvejic D, Savin S, Petrovie I,et al. Differential expression of ga- lectin-3 in papillary projections of malignant and nonmalignant hy- perplastic thyroid lesions [ J ]. Acta Chit Iugosl, 2003,50 ( 3 ) : 67 -70.
  • 9Wiseman S M, Melck A, Masoudi H, et al. Molecular phenoty- ping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis [ J ]. Ann Surg Oncol, 2008,15 ( 10 ) : 2811 -26.
  • 10Ziadi S, Trimeche M, Zermani R, et al. Diagnostic contribution of HBME-1 and anti-cytokeratin-19 antibodies in thyroid pathology: a retrospective study of 163 cases[ J]. Tunis Med,2005,83 (5) :274 -78.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部